20 results
424B3
BIAF
BioAffinity Technologies Inc
16 Apr 24
Prospectus supplement
7:19pm
in the diagnostics market.
Director Independence
Under the corporate governance standards of Nasdaq, a majority of our directors must meet … the independence requirements specified in those rules. The Nasdaq listing standards also subject members of the Company’s Audit Committee and Compensation
POS AM
BIAF
BioAffinity Technologies Inc
1 Apr 24
Prospectus update (post-effective amendment)
8:06pm
entities and her experience expanding product market share in the diagnostics market.
Director Independence
Under the corporate governance standards … of Nasdaq, a majority of our directors must meet the independence requirements specified in those rules. The Nasdaq listing standards also subject
DRS
x0hqa3qvx va
14 Aug 23
Draft registration statement
12:00am
DEF 14A
gwhl3r4ym2a fx
1 May 23
Definitive proxy
2:55pm
PRE 14A
xrz2c ywr
19 Apr 23
Preliminary proxy
9:56pm
10-K
sttfn0y 4l
31 Mar 23
Annual report
3:40pm
424B4
9ghwz61p3ib82 uf
2 Sep 22
Prospectus supplement with pricing info
3:25pm
S-1
bc0i2opt0 arn7eahs
25 Apr 22
IPO registration
6:16am
- Prev
- 1
- Next